Biocon
Signal active
Investment Firm
Overview
Biocon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. From discovery to development and commercialisation, Biocon has the defining science, cost-effective drug development capabilities and significant manufacturing capacity to move ideas to market.
Highlights
Founded
1978
Industry
Biotechnology
Employees
10001+
Investment
3
Lead Investment
1
Exits
2
Stages
Late Stage Venture, Seed
Investor Type
N/A
Location
India, Asia
Contact Information
Social
Profile Resume
Biocon, established in 1978 and headquartered in India, Asia., specializes in Late Stage Venture, Seed investments across Financial Services, Finance, FinTech, Banking, Insurance, Payments, Micro Lending, Leasing, Impact Investing, Venture Capital. The organization boasts a portfolio of 3 investments, with an average round size of $23.5M and 2 successful exits. Their recent investments include Fusion Microfinance, Creation Investments Capital Management, LLC, Oikocredit International, GAWA Capital, Bicara Therapeutics. The highest investment round they participated in was $3.0B. Among their most notable exits are Fusion Microfinance and Creation Investments Capital Management, LLC. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Biocon has made 3 investments. Their most recent investment was on Mar 15, 2021, when Bicara Therapeutics raised $40.0M.
investments
3
Diversity investments
1
Lead investments
1
Number of exits
2
Investments
3
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Dec 01, 2015 | - | - | 6.6M |
| Aug 11, 2016 | Fusion Microfinance | Financial Services | 24.0M |
| Mar 15, 2021 | Bicara Therapeutics | Biotechnology | 40.0M |
Fusion MicrofinanceExits
2
Funding Timeline
Funding rounds
3
Investors
1
Funds
0
Funding Rounds
3
Biocon has raised 3 rounds. Their latest funding was raised on Mar 15, 2021 from a Seed Round - Bicara Therapeutics round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Dec 01, 2015 | Seed Round - Glympse Bio | - | 6.6M | - |
| Aug 11, 2016 | Series D - Fusion Microfinance | - | 24.0M | - |
| Mar 15, 2021 | Seed Round - Bicara Therapeutics | - | 40.0M | - |
Investors
1
Biocon is funded by 1 investor(s). Kotak Investment Advisors Kantor is the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
Kotak Investment Advisors | Yes | Post-IPO Equity - Biocon | 129.2M |
Kotak Investment AdvisorsFund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.